ADC Therapeutics SA
US ˙ NYSE

SecurityADCT / ADC Therapeutics SA
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership399,721 shares
Latest Disclosed Value $ 1,498,954
Citadel Advisors Llc ownership in ADCT / ADC Therapeutics SA

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 399,721 shares of ADC Therapeutics SA (US:ADCT) valued at $1,498,954 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 298,218 shares of ADC Therapeutics SA. This represents a change in shares of 34.04% during the quarter. The current value of the position is $411,713 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (ADCT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ADCT / ADC Therapeutics SA Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ADC THERAPEUTICS SHS H0036K147 399,721 101,503 34.04 1,499 42.40 0.0002
2026-02-17 2025-12-31 13F ADC THERAPEUTICS SHS H0036K147 298,218 -522,497 -63.66 1,053 -67.95 0.0001
2025-11-14 2025-09-30 13F ADC THERAPEUTICS SHS H0036K147 820,715 791,709 2,729.47 3,283 4,162.34 0.0005
2025-08-14 2025-06-30 13F ADC THERAPEUTICS SHS H0036K147 29,006 29,006 78 0.0000
2024-11-14 2024-09-30 13F ADC THERAPEUTICS SHS H0036K147 0 -41,433 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ADC THERAPEUTICS SHS H0036K147 41,433 -911,031 -95.65 131 -96.96 0.0000
2024-05-15 2024-03-31 13F ADC THERAPEUTICS SHS H0036K147 952,464 -900,948 -48.61 4,277 39.01 0.0008
2024-02-14 2023-12-31 13F ADC THERAPEUTICS SHS H0036K147 1,853,412 -1,044,709 -36.05 3,077 18.35 0.0006
2023-11-14 2023-09-30 13F ADC THERAPEUTICS SHS H0036K147 2,898,121 -271,728 -8.57 2,600 -61.86 0.0006
2023-08-14 2023-06-30 13F ADC THERAPEUTICS SHS H0036K147 3,169,849 -196,855 -5.85 6,815 3.81 0.0014
2023-05-15 2023-03-31 13F ADC THERAPEUTICS SHS H0036K147 3,366,704 1,378,836 69.36 6,565 -13.99 0.0014
2023-02-14 2022-12-31 13F ADC THERAPEUTICS SHS H0036K147 1,987,868 1,948,077 4,895.77 7,633 3,875.52 0.0018
2022-11-14 2022-09-30 13F ADC THERAPEUTICS SHS H0036K147 39,791 39,791 192 0.0000
2022-02-14 2021-12-31 13F ADC THERAPEUTICS Cmn H0036K147 0 -19,346 -100.00 0 -100.00
2021-11-15 2021-09-30 13F ADC THERAPEUTICS Cmn H0036K147 19,346 -4,653 -19.39 525 -10.10 0.0001
2021-08-16 2021-06-30 13F ADC THERAPEUTICS SHS H0036K147 23,999 8,837 58.28 584 57.84 0.0001
2021-05-21 2021-03-31 13F/A-1 ADC THERAPEUTICS SHS H0036K147 15,162 -69,736 -82.14 370 -86.38 0.0001
2021-05-17 2021-03-31 13F ADC THERAPEUTICS SHS H0036K147 15,162 -69,736 370 0.0001
2021-02-16 2020-12-31 13F ADC THERAPEUTICS SHS H0036K147 84,898 84,898 2,717 0.0007
2020-11-16 2020-09-30 13F ADC THERAPEUTICS Cmn H0036K147 0 -29,738 -100.00 0 -100.00
2020-08-14 2020-06-30 13F ADC THERAPEUTICS Cmn H0036K147 29,738 29,738 1,392 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ADC THERAPEUTICS SHS Call 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F ADC THERAPEUTICS SHS Call 12,100 43 n/a n/a n/a
2025-11-14 2025-09-30 13F ADC THERAPEUTICS SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ADC THERAPEUTICS SHS Call 38,000 660.00 102 1,342.86 n/a n/a n/a
2025-05-15 2025-03-31 13F ADC THERAPEUTICS SHS Call 5,000 -1.96 7 -30.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ADC THERAPEUTICS SHS Call 5,100 -43.33 10 -64.29 n/a n/a n/a
2024-11-14 2024-09-30 13F ADC THERAPEUTICS SHS Call 9,000 -67.74 28 -68.18 n/a n/a n/a
2024-08-14 2024-06-30 13F ADC THERAPEUTICS SHS Call 27,900 1.09 88 -28.46 n/a n/a n/a
2024-05-15 2024-03-31 13F ADC THERAPEUTICS SHS Call 27,600 124 n/a n/a n/a
2024-02-14 2023-12-31 13F ADC THERAPEUTICS SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ADC THERAPEUTICS SHS Call 2,200 633.33 2 n/a n/a n/a
2023-08-14 2023-06-30 13F ADC THERAPEUTICS SHS Call 300 -57.14 1 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ADC THERAPEUTICS SHS Call 700 -87.27 1 -95.24 n/a n/a n/a
2023-02-14 2022-12-31 13F ADC THERAPEUTICS SHS Call 5,500 -47.62 21 -58.82 n/a n/a n/a
2022-11-14 2022-09-30 13F ADC THERAPEUTICS SHS Call 10,500 -47.24 51 -67.72 n/a n/a n/a
2022-08-15 2022-06-30 13F ADC THERAPEUTICS SHS Call 19,900 3.65 158 -43.97 n/a n/a n/a
2022-05-16 2022-03-31 13F ADC THERAPEUTICS SHS Call 19,200 -11.93 282 -35.91 n/a n/a n/a
2022-02-14 2021-12-31 13F ADC THERAPEUTICS SHS Call 21,800 440 n/a n/a n/a
2022-03-11 2021-09-30 13F/A ADC THERAPEUTICS SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F ADC THERAPEUTICS SHS Call 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F ADC THERAPEUTICS SHS Call 15,300 35.40 373 35.14 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ADC THERAPEUTICS SHS Call 11,300 59.15 276 21.59 n/a n/a n/a
2021-05-17 2021-03-31 13F ADC THERAPEUTICS SHS Call 11,300 276 n/a n/a n/a
2021-02-16 2020-12-31 13F ADC THERAPEUTICS SHS Call 7,100 227 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F ADC THERAPEUTICS SHS Put 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F ADC THERAPEUTICS SHS Put 19,600 4.26 78 56.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ADC THERAPEUTICS SHS Put 18,800 147.37 50 400.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ADC THERAPEUTICS SHS Put 7,600 -51.90 11 -67.74 n/a n/a n/a
2025-02-14 2024-12-31 13F ADC THERAPEUTICS SHS Put 15,800 -49.84 31 -68.69 n/a n/a n/a
2024-11-14 2024-09-30 13F ADC THERAPEUTICS SHS Put 31,500 10.53 99 10.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ADC THERAPEUTICS SHS Put 28,500 5.17 90 -25.62 n/a n/a n/a
2024-05-15 2024-03-31 13F ADC THERAPEUTICS SHS Put 27,100 1,494.12 122 5,950.00 n/a n/a n/a
2024-02-14 2023-12-31 13F ADC THERAPEUTICS SHS Put 1,700 -68.52 3 -50.00 n/a n/a n/a
2023-11-14 2023-09-30 13F ADC THERAPEUTICS SHS Put 5,400 -51.35 5 -82.61 n/a n/a n/a
2023-08-14 2023-06-30 13F ADC THERAPEUTICS SHS Put 11,100 -5.93 24 0.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ADC THERAPEUTICS SHS Put 11,800 47.50 23 -23.33 n/a n/a n/a
2023-02-14 2022-12-31 13F ADC THERAPEUTICS SHS Put 8,000 31 n/a n/a n/a
2022-11-14 2022-09-30 13F ADC THERAPEUTICS SHS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ADC THERAPEUTICS SHS Put 14,700 24.58 117 -32.37 n/a n/a n/a
2022-05-16 2022-03-31 13F ADC THERAPEUTICS SHS Put 11,800 173 n/a n/a n/a
2022-03-11 2021-09-30 13F/A ADC THERAPEUTICS SHS Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F ADC THERAPEUTICS SHS Put 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F ADC THERAPEUTICS SHS Put 27,000 10.66 657 10.23 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ADC THERAPEUTICS SHS Put 24,400 596 n/a n/a n/a
2021-05-17 2021-03-31 13F ADC THERAPEUTICS SHS Put 24,400 596 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.